Guardian Capital LP Astrazeneca PLC Transaction History

Guardian Capital LP

$2.47 Billion
Q3 2024

A detailed history of Guardian Capital LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Capital LP holds 54,454 shares of AZN stock, worth $3.61 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

54,454

Previous 55,979 2.72%

Holding current value

$3.61 Million

Previous $4.37 Million 2.79%

% of portfolio

0.17%

Previous 0.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $116,921 - $133,620	-1,525 Reduced 2.72%	54,454 $4.24 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $247,531 - $299,475	3,705 Added 7.09%	55,979 $4.37 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $304,234 - $346,806	4,985 Added 10.54%	52,274 $3.54 Million
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $298,928 - $334,622	-4,830 Reduced 9.27%	47,289 $3.18 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $112,514 - $124,399	-1,735 Reduced 3.22%	52,119 $3.53 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $87,806 - $95,217	-1,256 Reduced 2.28%	53,854 $3.85 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $159,895 - $181,291	-2,532 Reduced 4.39%	55,110 $3.83 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $71,990 - $93,544	-1,328 Reduced 2.25%	57,642 $3.91 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $177,829 - $455,305	3,354 Added 6.03%	58,970 $3.23 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $1.15 Million - $1.39 Million	19,474 Added 53.88%	55,616 $3.68 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $16,270 - $19,599	292 Added 0.81%	36,142 $2.4 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $191,716 - $226,532	-3,549 Reduced 9.01%	35,850 $2.09 Million
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $45,725 - $50,030	-823 Reduced 2.05%	39,399 $2.37 Million
Q2 2021 Aug 17, 2021	BUY	$48.42 - $60.18 $16,414 - $20,401	339 Added 0.85%	40,222 $2.41 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $790,024 - $911,978	-16,752 Reduced 29.58%	39,883 $1.98 Million
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $3,396 - $4,061	-70 Reduced 0.12%	56,635 $2.83 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $6,952 - $8,004	131 Added 0.23%	56,705 $3.11 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $14,654 - $18,805	-340 Reduced 0.6%	56,574 $2.99 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $836,632 - $1.14 Million	22,139 Added 63.66%	56,914 $2.54 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $2.29 Million - $2.73 Million	-54,021 Reduced 60.84%	34,775 $1.73 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $723,243 - $819,687	18,027 Added 25.47%	88,796 $3.96 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $146,808 - $164,135	3,938 Added 5.89%	70,769 $2.92 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $2.17 Million - $2.63 Million	-61,153 Reduced 47.78%	66,831 $2.7 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $496,909 - $559,326	-13,481 Reduced 9.53%	127,984 $4.86 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $75,324 - $86,073	-2,167 Reduced 1.51%	141,465 $5.6 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $451,084 - $483,724	-13,056 Reduced 8.33%	143,632 $5.04 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $84,666 - $94,065	-2,568 Reduced 1.61%	156,688 $5.48 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $113,020 - $122,495	-3,522 Reduced 2.16%	159,256 $5.53 Million
Q3 2017 Nov 15, 2017	SELL	$28.96 - $34.0 $92,672 - $108,800	-3,200 Reduced 1.93%	162,778 $5.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	165,978	165,978 $5.66 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.

Account

Guardian Capital LP Astrazeneca PLC Transaction History